12.61
price up icon6.86%   0.81
after-market 시간 외 거래: 12.61
loading
전일 마감가:
$11.80
열려 있는:
$12
하루 거래량:
249.92K
Relative Volume:
1.11
시가총액:
$493.84M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+8.43%
1개월 성능:
+7.14%
6개월 성능:
-36.86%
1년 성능:
+0.00%
1일 변동 폭
Value
$11.81
$12.79
1주일 범위
Value
$10.83
$12.79
52주 변동 폭
Value
$5.485
$31.13

Oruka Therapeutics Inc Stock (ORKA) Company Profile

Name
명칭
Oruka Therapeutics Inc
Name
전화
650-606-7910
Name
주소
855 OAK GROVE AVE., MENLO PARK
Name
직원
28
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
ORKA's Discussions on Twitter

ORKA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ORKA
Oruka Therapeutics Inc
12.61 493.84M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-22 개시 BTIG Research Buy
2025-02-04 개시 Wolfe Research Outperform
2024-10-11 개시 Stifel Buy
2024-10-07 개시 H.C. Wainwright Buy
2024-09-17 개시 Leerink Partners Outperform
2024-09-16 개시 TD Cowen Buy
2024-09-13 개시 Jefferies Buy
2018-02-27 개시 Ascendiant Capital Markets Buy
2013-10-09 개시 Dawson James Buy
모두보기

Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스

pulisher
Jun 14, 2025

Wall Street Zen Downgrades Oruka Therapeutics (NASDAQ:ORKA) to Sell - Defense World

Jun 14, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Makes New Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Acquires New Stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 Trial - MSN

Jun 06, 2025
pulisher
Jun 03, 2025

Oruka Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

Jane Street Group LLC Buys New Shares in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

HC Wainwright Has Positive Estimate for ORKA Q2 Earnings - Defense World

May 30, 2025
pulisher
May 29, 2025

Northern Trust Corp Acquires Shares of 64,044 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

May 29, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains Buy on Oruka stock, $45 target By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains Buy on Oruka stock, $45 target - Investing.com UK

May 27, 2025
pulisher
May 26, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 26, 2025
pulisher
May 25, 2025

Oruka Therapeutics (NASDAQ:ORKA) Upgraded at BTIG Research - Defense World

May 25, 2025
pulisher
May 22, 2025

BTIG Initiates Oruka Therapeutics at Buy With $44 Price Target - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

BTIG sets $44 price target on Oruka Therapeutics stock - Investing.com UK

May 22, 2025
pulisher
May 21, 2025

Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 21, 2025
pulisher
May 20, 2025

Oruka Therapeutics begins trial for psoriasis treatment By Investing.com - Investing.com South Africa

May 20, 2025
pulisher
May 20, 2025

Oruka Therapeutics begins trial for psoriasis treatment - Investing.com Australia

May 20, 2025
pulisher
May 20, 2025

Oruka Therapeutics Begins Dosing in Phase 1 Trial of ORKA-002 for Skin Disease Treatment - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

Revolutionary Psoriasis Treatment Begins Human Trials: Only 2-3 Doses Per Year Needed - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Wedbush Forecasts Reduced Earnings for Oruka Therapeutics - Defense World

May 19, 2025
pulisher
May 18, 2025

What is Wedbush’s Estimate for ORKA FY2029 Earnings? - Defense World

May 18, 2025
pulisher
May 17, 2025

Wedbush Reaffirms “Outperform” Rating for Oruka Therapeutics (NASDAQ:ORKA) - Defense World

May 17, 2025
pulisher
May 17, 2025

Oruka Therapeutics (NASDAQ:ORKA) versus Trinity Biotech (NASDAQ:TRIB) Critical Analysis - Defense World

May 17, 2025
pulisher
May 14, 2025

Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Oruka Therapeutics Announces Accelerated Clinical Timelines and Strong Financial Position for Psoriasis Programs - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Oruka Therapeutics Reports First Quarter 2025 Financial Results And Provides Corporate Update - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Oruka Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 12, 2025

Oruka Therapeutics (NASDAQ:ORKA) and Trinity Biotech (NASDAQ:TRIB) Head-To-Head Analysis - Defense World

May 12, 2025
pulisher
May 07, 2025

JPMorgan Chase & Co. Acquires New Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

May 07, 2025
pulisher
May 04, 2025

Barclays PLC Purchases Shares of 74,583 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

May 04, 2025
pulisher
May 02, 2025

HC Wainwright Issues Negative Estimate for ORKA Earnings - Defense World

May 02, 2025
pulisher
May 01, 2025

Equities Analysts Offer Predictions for ORKA Q1 Earnings - Defense World

May 01, 2025
pulisher
Apr 29, 2025

Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference - GlobeNewswire

Apr 29, 2025
pulisher
Apr 26, 2025

Geode Capital Management LLC Boosts Stock Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Comparing TNF Pharmaceuticals (NASDAQ:TNFA) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Apr 26, 2025
pulisher
Apr 21, 2025

Oruka Therapeutics Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView

Apr 21, 2025
pulisher
Apr 17, 2025

Oruka Therapeutics (ORKA) Projected to Post Quarterly Earnings on Thursday - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Vanguard Group Inc. Purchases 1,572,853 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA) - The AM Reporter

Apr 15, 2025
pulisher
Apr 15, 2025

Vanguard Group Inc. Acquires 1,572,853 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 15, 2025
pulisher
Apr 13, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Shares Acquired by Wellington Management Group LLP - Defense World

Apr 13, 2025
pulisher
Apr 06, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 06, 2025
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Takes Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 02, 2025
pulisher
Mar 24, 2025

Contrasting Achieve Life Sciences (NASDAQ:ACHV) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Mar 24, 2025

Oruka Therapeutics Inc (ORKA) 재무 분석

Oruka Therapeutics Inc (ORKA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Oruka Therapeutics Inc 주식 (ORKA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Venrock Healthcare Capital Par
10% Owner
Feb 13 '25
Buy
11.63
14,950
173,868
4,059,634
Venrock Healthcare Capital Par
10% Owner
Feb 12 '25
Buy
11.86
8,971
106,396
4,044,684
Venrock Healthcare Capital Par
10% Owner
Feb 11 '25
Buy
10.95
9,593
105,043
4,035,713
Venrock Healthcare Capital Par
10% Owner
Feb 10 '25
Buy
10.90
574
6,257
4,026,120
JANUS HENDERSON GROUP PLC
10% Owner
Aug 16 '24
Buy
2.93
5,818
17,067
2,117,213
JANUS HENDERSON GROUP PLC
10% Owner
Jul 24 '24
Buy
3.20
189,856
606,873
2,081,168
JANUS HENDERSON GROUP PLC
10% Owner
Jul 25 '24
Buy
3.05
30,227
92,292
2,111,395
JANUS HENDERSON GROUP PLC
10% Owner
Jul 03 '24
Buy
3.55
166,042
589,565
1,648,577
JANUS HENDERSON GROUP PLC
10% Owner
Jul 11 '24
Buy
3.45
94,537
326,304
1,891,312
JANUS HENDERSON GROUP PLC
10% Owner
Jul 10 '24
Buy
3.46
55,463
192,130
1,796,775
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):